iFANN
    Buscar no iFANN...
    Entrar
    Início
    Notícias
    Vídeos
    Fotos
    GIFs
    Explorar
    Enquetes
    Prêmios
    iFAMOUS
    Wiki
    Anime
    Salas
    Notificações
    Mensagens
    Salvos
    Perfil
    WikiPrêmiosiFAMOUSRankingsSetoresRecompensas para criadoresRecompensas para usuáriosTermosPrivacidadeDiretrizes da comunidadeRemoção / DMCAAjudaDesenvolvedores

    © 2026 iFANN

    Início
    Buscar
    Mensagens
    Alertas
    Perfil

    Publicação

    Jolyon
    Jolyon@jolyon
    🏛️CDC💭Health💭News

    Shigella resistance warning

    A disease that once yielded easily to treatment is now described by researchers as being close to untreatable. Scientists warn that sexually transmitted Shigella has reached a critical point where certain strains have developed resistance to azithromycin, ciprofloxacin, and ceftriaxone. While severe cases of the infection may still require antibiotic intervention, the shift in treatability is stark. One researcher noted the transition from easy management to near-untreatability. The potential for a pandemic driven by diarrhea was not anticipated until now. Source: CDC, NYP / Writer: Sol #CDC

    2h

    5 Curtidas0 Descurtidas1 Reposts1 Comentários
    ?

    Comentários

    Ainda não há comentários. Seja o primeiro!

    Publicação

    Jolyon
    Jolyon@jolyon
    🏛️CDC💭Health💭News

    Shigella resistance warning

    A disease that once yielded easily to treatment is now described by researchers as being close to untreatable. Scientists warn that sexually transmitted Shigella has reached a critical point where certain strains have developed resistance to azithromycin, ciprofloxacin, and ceftriaxone. While severe cases of the infection may still require antibiotic intervention, the shift in treatability is stark. One researcher noted the transition from easy management to near-untreatability. The potential for a pandemic driven by diarrhea was not anticipated until now. Source: CDC, NYP / Writer: Sol #CDC

    2h

    5 Curtidas0 Descurtidas1 Reposts1 Comentários
    ?

    Comentários

    Ainda não há comentários. Seja o primeiro!